Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8744951 | Clinical Microbiology and Infection | 2018 | 12 Pages |
Abstract
With the exception of VEGF-targeted agents, the overall risk of infection associated with the reviewed therapies seems to be low.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
J. Aguilar-Company, M. Fernández-Ruiz, R. GarcÃa-Campelo, A.C. Garrido-Castro, I. Ruiz-Camps,